You have a vision. You have great data. You have a pitch. Now, how do you get money and from the right investor? Join a conversation about the inside baseball of raising your first and second rounds of venture capital.
Julie Papanek, a Partner at Canaan Partners, will talk about the subtle tips and tricks of raising money from early stage life science venture capital funds.
Topics will include:
- Preparing to raise funds
- Pre-qualifying a fund
- Securing an introduction
- Questions you should ask
- Maintaining momentum
Don't miss this unique insider's look at raising life science capital. Gain the knowledge to improve your odds for funding success. Bring your questions to this interactive session!
Julie Papanek | Partner, Canaan Partners
10:30 AM | Registration and Networking
11:00 AM | Presentation
11:30 AM | Q&A
12:00 PM | Food and Networking
1:00 PM | Program Close
$25 | General Public
$15 | Student
$45 | At the door
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Julie Papanek is a Partner at Canaan Partners where she concentrates on biopharmaceutical, digital health and consumer medical device investments. Julie currently sits on the board of Protagonist Therapeutics (PTGX) and has also worked closely with and observed on the boards of CytomX, Labrys Biologics, Dermira, ALDEA Pharmaceuticals, Chrono Therapeutics, and Glooko. Prior to Canaan, Julie worked at Genentech in a variety of positions spanning marketing, development, and business development.
Julie earned her MBA from Stanford¹s Graduate School of Business, MPhil from Cambridge in BioScience Enterprise and B.S. from Yale in Molecular Biophysics and Biochemistry.
Save This Event
When & Where
JLABS Bay Area
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.